Health Care & Life Sciences » Pharmaceuticals | Mangalam Drugs & Organics Ltd.

Mangalam Drugs & Organics Ltd. | Income Statement

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
1,222
2,126
2,950
2,985
2,794
Cost of Goods Sold (COGS) incl. D&A
1,102
1,949
2,474
2,411
1,929
Gross Income
120
178
476
574
865
SG&A Expense
66
91
141
129
462
EBIT
53
161
333
446
403
Unusual Expense
-
-
-
3
-
Non Operating Income/Expense
5
2
-
9
8
Interest Expense
97
103
93
100
118
Pretax Income
39
60
240
334
293
Income Tax
9
1
80
97
95
Consolidated Net Income
30
61
160
237
199
Net Income
30
61
160
237
199
Net Income After Extraordinaries
30
61
160
237
199
Net Income Available to Common
30
61
160
237
199
EPS (Basic)
2.31
4.66
11.15
14.97
12.57
Basic Shares Outstanding
13
13
14
16
-
EPS (Diluted)
2.31
4.66
10.13
14.97
-
Diluted Shares Outstanding
13
13
16
16
-
EBITDA
93
203
377
496
469
Other Operating Expense
1
75
2
1
-

About Mangalam Drugs & Organics

View Profile
Address
Rupam Building
Mumbai Maharashtra 400001
India
Employees -
Website http://www.mangalamdrugs.com
Updated 09/14/2018
Mangalam Drugs & Organics Ltd. engages in the manufacture of drugs, medicines and allied products. Its products include Allopurinol, Amodiaquin, Dichloroquinoline, Menthol, Lumefantrine, Amodiaquine Hydrochloride and Artemether. The company was founded in 1977 and is headquartered in Mumbai, India.